Tearscience
Latest round
- Series D
Last raised
- Mar 2016
Total raised
- $74M
Investors
- 6
About Tearscience
Tearscience, Inc.Tearscience, Inc. is focused on treating Meibomian Gland Dysfunction, established in 2005 and headquartered in Morrisville, US. The company has undergone no known strategic pivots and remains an independent entity.Tearscience, Inc. provides innovative solutions for ocular health, focusing on Meibomian Gland Dysfunction. Their flagship product, the TearScience™ technology, aids healthcare professionals in managing ocular surface issues, particularly in patients experiencing discomfort from contact lenses.Revenue generation at Tearscience, Inc. is achieved through direct sales to healthcare providers, partnerships with optometry practices, and collaborations with wholesalers and retailers. The company leverages its TearScience™ technology alongside products like ACUVUE® contact lenses to foster business transactions, focusing on B2B partnerships within the eye care sector.Tearscience, Inc. The company is focused on the launch of new technologies aimed at improving the treatment of Meibomian Gland Dysfunction, with plans to enter additional markets in North America and Europe by the end of 2023.
Who invested in Tearscience
6 investors across 4 rounds
See all investors in Tearscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tearscience
Who invested in Tearscience?
Tearscience has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tearscience raised?
Tearscience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Tearscience last raise money?
Tearscience's most recent round on record is a Series D, in Mar 2016.
What does Tearscience do?
Tearscience is a medical devices & equipment company.
Where is Tearscience headquartered?
Tearscience is headquartered in Morrisville, US.
Which VCs invest in companies like Tearscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Tearscience's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Tearscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.